Definition and Basic Concepts
- Short stature is defined as a height below the third centile or more than two standard deviation scores (SDS) below the median height for age and gender (←2 SDS) according to population standards.
- Children whose stature is more than 3 SDS below the population mean for age and gender (←3 SDS) are highly likely to be suffering from pathological short stature, whereas those between -2 and -3 SDS commonly have physiological variants.
- Growth failure must be actively distinguished from static short stature; growth failure is defined as an abnormally low height velocity for age and sex, or a downward crossing of more than two major percentile lines on a standard growth chart.
- Accurate assessment relies on measuring height velocity, which averages 25 cm/year in the first year, decelerates to 4-6 cm/year in prepubertal children (4 to 9 years of age), and peaks at 8-12 cm/year during the pubertal growth spurt.
Etiology and Classification
- Short stature can be broadly categorized into physiological (normal variants) and pathological causes, with the latter further subdivided into proportionate and disproportionate short stature.
| Category | Specific Etiologies |
|---|---|
| Normal Variants | Familial (genetic) short stature, Constitutional delay of growth and puberty (CDGP). |
| Pathological (Proportionate) | Chronic systemic illness (cerebral palsy, congenital heart disease, cystic fibrosis, asthma, chronic kidney disease). |
| Pathological (Proportionate) | Undernutrition, malabsorption syndromes (e.g., celiac disease, chronic liver disease). |
| Pathological (Proportionate) | Endocrine causes (Growth hormone deficiency or insensitivity, hypothyroidism, Cushing syndrome, poorly controlled diabetes mellitus). |
| Pathological (Proportionate) | Children born small for gestational age (SGA) with inadequate catch-up growth. |
| Pathological (Proportionate) | Psychosocial dwarfism (emotional deprivation). |
| Pathological (Proportionate) | Genetic and chromosomal syndromes (Turner syndrome, Down syndrome, Prader-Willi syndrome, Noonan syndrome). |
| Pathological (Disproportionate) | Skeletal dysplasias (e.g., achondroplasia, hypochondroplasia, osteogenesis imperfecta). |
| Pathological (Disproportionate) | Rickets, spinal anomalies (Caries spine, hemivertebra), metabolic bone disease. |
| Idiopathic | Idiopathic short stature (ISS) where no specific nutritional, endocrine, or genetic abnormality is identified. |
Specific Etiological Profiles
- Familial Short Stature: The child’s height is below the 3rd centile but is entirely appropriate for the genetic potential determined by the parents’ heights.
- Constitutional Delay of Growth and Puberty (CDGP): Children are born with normal size, decelerate growth in the first year, and then grow parallel to the 3rd centile; they experience a delayed pubertal growth spurt but achieve a normal final adult height.
- Small for Gestational Age (SGA): Approximately 10-15% of babies born SGA fail to demonstrate catch-up growth by two years of age, remaining persistently short due to subtle defects in the growth hormone-insulin-like growth factor (GH-IGF) axis.
- Psychosocial Dwarfism: Seen in emotionally neglected children, characterized by functional hypopituitarism with low IGF-1 levels and inadequate response to GH stimulation; rapid catch-up growth occurs upon removal from the stressful environment.
- Turner Syndrome: Affects 1 in 2000 live-born girls; short stature may be the only presenting feature, mandating chromosomal evaluation (karyotype) in all girls presenting with unexplained short stature.
Clinical Approach and History Taking
- A comprehensive medical, nutritional, and developmental history is crucial for identifying underlying chronic illnesses or genetic traits.
- The birth history must clarify if the child was born premature or small for gestational age, as this dictates the expected growth trajectory.
- The physician must inquire about the timing of puberty in both parents, as a delayed pubertal spurt in a parent strongly supports a diagnosis of CDGP.
| History Finding | Potential Etiological Clue |
|---|---|
| Low birth weight / IUGR | Small for gestational age (SGA) without catch-up, intrauterine infections (TORCH). |
| Polyuria, polydipsia | Chronic renal failure, renal tubular acidosis, diabetes insipidus. |
| Chronic diarrhea, greasy stools | Malabsorption syndromes (e.g., celiac disease, cystic fibrosis). |
| Neonatal hypoglycemia, prolonged jaundice, micropenis | Congenital hypopituitarism. |
| Headache, vomiting, visual field defects | Pituitary or hypothalamic space-occupying lesion (e.g., craniopharyngioma). |
| Lethargy, constipation, cold intolerance | Hypothyroidism. |
| Inadequate dietary intake, prolonged exclusive breastfeeding | Undernutrition, protein-energy malnutrition. |
| Delayed puberty in parents | Constitutional delay of growth and puberty (CDGP). |
Physical Examination and Anthropometry
- Height must be measured accurately using an infantometer for children under two years and a stadiometer for older children, ensuring the head is in the Frankfurt plane without shoes.
- The mid-parental height (MPH) must be calculated to establish the child’s genetic target height; for boys, it is [(Mother’s height + Father’s height + 13 cm) / 2], and for girls, [(Mother’s height + Father’s height - 13 cm) / 2].
- A target range of approximately 4 inches (or 6.5 cm) above and below the MPH is used to define the expected genetic height potential.
- Body proportions must be evaluated by calculating the upper segment to lower segment (US/LS) ratio, which is normally 1.7 at birth, 1.3 at 3 years, and 1.0 by 7 to 10 years of age.
- An increased US/LS ratio (short limbs) suggests skeletal dysplasias like achondroplasia or untreated congenital hypothyroidism, whereas a decreased ratio (short trunk) suggests spinal anomalies or mucopolysaccharidosis.
- Arm span is normally shorter than height by 2.5 cm at birth, equals height by 10 to 11 years, and slightly exceeds height in adulthood.
| Physical Examination Finding | Potential Etiological Clue |
|---|---|
| Disproportionate growth (abnormal US/LS ratio) | Skeletal dysplasia, severe rickets, severe hypothyroidism. |
| Dysmorphic facial features or webbed neck | Congenital syndromes (Turner syndrome, Noonan syndrome, Down syndrome). |
| Pallor, clubbing, or chronic hypoxia signs | Chronic anemia, chronic kidney disease, congenital heart disease, malabsorption. |
| Hypertension | Chronic kidney disease, Turner syndrome, Cushing syndrome. |
| Frontal bossing, depressed nasal bridge, small penis | Hypopituitarism. |
| Goiter, coarse dry skin, sparse hair | Hypothyroidism. |
| Central obesity, purple striae, hirsutism | Cushing syndrome. |
| Costochondral beading, wrist widening, Harrison sulcus | Rickets. |
Diagnostic Investigations
- The initial and most critical diagnostic imaging is a radiograph of the left hand and wrist to assess bone age (skeletal maturation).
- Bone age helps determine the proportion of adult height already achieved and predicts remaining growth potential.
Interpretation of Bone Age Patterns
| Bone Age (BA) Pattern | Clinical Interpretation | Typical Etiologies |
|---|---|---|
| Pattern A: BA = Chronological Age (CA) | Normal skeletal maturation; growth is appropriate for genetic potential. | Familial Short Stature. |
| Pattern B: BA < CA, and HA = BA | Delayed skeletal maturation proportional to the delayed height age; catch-up is expected. | Constitutional Delay of Growth and Puberty (CDGP). |
| Pattern C: BA < HA < CA | Severe delay in skeletal maturation; growth is disproportionately affected compared to skeletal age. | Endocrine disorders (Growth Hormone Deficiency, Hypothyroidism). |
| Pattern D: BA mildly < CA, and HA < CA | Height is severely impacted, but bone age is only mildly delayed. | Chronic systemic illness, severe undernutrition, prolonged organ dysfunction. |
Tiered Laboratory Workup
- A tiered approach to laboratory investigation is recommended to systematically rule out systemic, nutritional, and endocrine causes.
| Investigation Level | Specific Tests Included | Diagnostic Purpose |
|---|---|---|
| Level 1 (Essential Screening) | Complete blood count with ESR, Urinalysis (microscopy, osmolality, pH), Stool examination (parasites, occult blood, steatorrhea). | Screen for chronic infections, anemia, renal tubular acidosis, and malabsorption syndromes. |
| Level 1 (Metabolic/Bone) | Blood urea, creatinine, electrolytes (bicarbonate, Ca, P, ALP), fasting glucose, albumin, LFTs. | Evaluate for chronic kidney disease, rickets, liver failure, and severe malnutrition. |
| Level 2 (Specific Endocrine & Genetic) | Serum free T4, TSH, Celiac serology (tissue transglutaminase antibodies). | Rule out hypothyroidism and occult celiac disease. |
| Level 2 (Karyotype) | Standard Karyotype (or chromosomal microarray) strictly in all females. | Rule out Turner syndrome, regardless of the presence or absence of classic dysmorphic features. |
| Level 3 (Advanced Endocrine) | Serum IGF-1, IGFBP-3, Provocative growth hormone testing. | Confirm Growth Hormone Deficiency or insensitivity. |
| Level 3 (Imaging) | MRI Brain (focusing on the pituitary gland and hypothalamus). | Identify anatomical defects or space-occupying lesions (e.g., craniopharyngioma) if GH deficiency is confirmed. |
| Targeted Imaging | Complete skeletal survey (radiographs of skull, spine, pelvis, limbs). | Required for all patients presenting with disproportionate short stature to diagnose specific skeletal dysplasias. |
Principles of Management
- The foundation of management involves identifying the specific underlying pathology, providing dietary advice to ensure adequate macro- and micronutrient intake, and counseling parents regarding expectations.
- For normal physiological variants (Familial Short Stature and CDGP), management primarily consists of reassurance, counseling to support the child’s self-esteem, and routine annual monitoring of height velocity without pharmacological intervention.
- Undernutrition and chronic illnesses (e.g., celiac disease, renal tubular acidosis) require targeted nutritional rehabilitation and medical therapy, which typically leads to rapid catch-up growth.
- Primary hypothyroidism is treated aggressively with daily levothyroxine replacement therapy to restore linear growth and prevent developmental delay.
- Recombinant human growth hormone (rhGH) therapy, administered via daily subcutaneous injections, is the definitive treatment for confirmed Growth Hormone Deficiency.
- rhGH therapy is also FDA-approved and highly recommended for optimizing final adult height in several non-GH deficient conditions, including Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and in children born SGA who fail to demonstrate catch-up growth by two years of age.
- In cases of severe skeletal dysplasia (e.g., achondroplasia), specialized orthopedic interventions, including surgical limb-lengthening procedures, may be considered at dedicated centers.
- For selected pubertal patients with CDGP experiencing significant psychosocial distress due to extreme delay, a brief course of low-dose sex steroids may occasionally be utilized to initiate the pubertal growth spurt and secondary sexual characteristics.